Ciprostene calcium salt is primarily used in medical research and therapeutic applications due to its properties as a stable prostacyclin analog. It is studied for its potential to inhibit platelet aggregation, making it valuable in the prevention of thrombosis, particularly in conditions like peripheral vascular disease and pulmonary hypertension. Its vasodilatory effects are also explored for improving blood flow in patients with circulatory disorders. Additionally, it has been investigated for its role in protecting tissues during ischemia-reperfusion injury, offering potential benefits in organ transplantation and cardiovascular surgeries. Research continues to explore its efficacy in managing inflammatory conditions and its potential use in other vascular-related diseases.